Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus

This publication has 25 references indexed in Scilit:

• Improving quality improvement using achievable benchmarks for physician feedback. A randomized controlled trial
  American Journal of Ophthalmology, 2001
• Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study
  Diabetes Research and Clinical Practice, 2001
• Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment
  European Heart Journal, 2001
• The Oregon Health Plan
  Diabetes Care, 2001
• The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus
  Archives of internal medicine (1960), 2000
• Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.
  JAMA, 2000
• Risk Factors for Hospitalization in People With Diabetes
  Archives of internal medicine (1960), 1999
• Clustering of Metabolic Factors and Coronary Heart Disease
  Archives of internal medicine (1960), 1999
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
  BMJ, 1998